CellaVision AB (publ) (LON:0MR5)
187.70
-8.70 (-4.43%)
At close: Feb 20, 2025
CellaVision AB Revenue
In the year 2024, CellaVision AB had annual revenue of 723.22M SEK with 6.78% growth. CellaVision AB had revenue of 186.69M in the quarter ending December 31, 2024, a decrease of -6.95%.
Revenue
723.22M SEK
Revenue Growth
+6.78%
P/S Ratio
n/a
Revenue / Employee
3.17M SEK
Employees
228
Market Cap
329.73M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |